Kang, Y., Liao, D., Xie, W., Liu, L., Zhang, Y., Mei, H. (2025). Lipo-MIT-based bridging therapy enables effective CAR-T treatment in high-risk relapsed or refractory B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-5935